市场调查报告书
商品编码
1542915
全球美国医用黏合剂和密封剂市场 - 2024-2031U.S. Medical Adhesives and Sealants Market - 2024-2031 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
报告概述
美国医用黏合剂和密封剂市场在2023年达到44.3亿美元,预计到2031年将达到72.9亿美元,在2024-2031年预测期间复合年增长率为6.6%。
医用黏合剂和密封剂是外科手术过程中常用于黏合应用的化学製剂。它们由多种製造材料组成,由适合皮肤和海豹的合成和天然配方组成。
由于其非侵入性和成本效益等优点,它们成为外科手术的理想选择。
驱动程式和限制
外科手术数量不断增加
外科手术数量的增加以及该产品在心血管、牙科手术等各种外科手术中的使用量不断增加是推动市场成长的主要因素之一。这是因为它们的使用被证明具有积极的手术效果,例如减少併发症、减少失血和缩短止血时间。
例如,根据 DMC Org 的出版物。据估计,美国每年约有50万人接受心臟直视手术以矫正各种心血管疾病。
此外,根据美国整形外科医生协会 2022 年的报告,2022 年大约进行了 576,485 例手术。
监管挑战
医用黏合剂和密封剂的严格法规和审批程序可能会限制产品进入市场。监管机构对安全性、有效性和生物相容性制定了严格的标准,以确保医用黏合剂和密封剂不会对患者健康构成风险。
Report Overview
The U.S. medical adhesives and sealants market reached US$ 4.43 billion in 2023 and is expected to reach US$ 7.29 billion by 2031, growing at a CAGR of 6.6% during the forecast period 2024-2031.
Medical adhesives and sealants are chemical formulations commonly used for bonding applications during surgical procedures. They comprise a wide range of fabrication materials and are composed of synthetic and natural formulations suitable for skin and seals.
They became the ideal choice for surgical procedures owing to advantages offered by them such as non-invasiveness and cost-effectiveness.
Market Dynamics: Drivers & Restraints
Rising number of surgical procedures
The rising number of surgical procedures along with the growing usage of the product in various surgical procedures such as cardiovascular, dental surgeries, and others is one of the major factors boosting the market growth. It is because their usage is proven to have positive surgical outcomes such as reduced complications, reduced blood loss, and improved time to hemostasis.
For instance, according to the publication by DMC Org. it is estimated that approximately 500,000 people undergo open-heart surgery each year in the United States to correct various cardiovascular diseases.
Additionally, according to the report by the American Society of Plastic Surgeons in 2022 it is stated that around 576,485 procedures were performed in 2022. Thus, the increasing number of surgical procedures are expected to drive market growth in the region.
Regulatory Challenges
Stringent regulations and approval processes for medical adhesives and sealants could restrict the products from entering the market. Regulatory agencies impose stringent standards for safety, efficacy, and biocompatibility to ensure that medical adhesives and sealants do not pose risks to patient health.
The U.S. medical adhesives and sealants market is segmented based on type, application, end-users and region.
Natural segment is expected to dominate the market growth
The natural medical adhesives and sealants segment is expected to hold a dominant position during the forecast period. The products include fibrin, albumin, collagen, and others. Among all these, collagen is the most commonly used natural medical adhesive and sealant due to its excellent bond strength, elasticity, and biocompatibility. Also, it is a protein constituent in the animal connective tissue and has excellent adhesive properties.
Natural adhesives and sealants are often chosen in medical applications because they are made from natural sources such as proteins, peptides, and polysaccharides. These materials are naturally biocompatible, indicating that they are less likely to cause harm when in contact with body tissues or fluids. Natural adhesives and sealants have a smaller environmental impact than their synthetic equivalents because they are made from renewable resources and are biodegradable.
Synthetic
Acrylic
Silicones
Cyanoacrylate
Polyethylene Glycol
Others
Natural
Collagen
Fibrin
Albumin
Others
Dental Applications
Internal
Bone
Cardiovascular
Abdominal
Others
External
Tissue Bonding
Prosthesis Bonding
Others
Hospitals and Clinics
Ambulatory Surgical Centers (ASCs)
Research and Academic Institutions
Others
The major players in the market include 3M Company, Baxter International Inc., Berry Plastics Corporation, Medtronic Plc, DENTSPLY International Inc., Johnson & Johnson, DuPont and Master Bond Inc. among others.
On January 11, 2023, H.B. Fuller launched Swiftmelt 1515-I, its first bio-compatible product compliant in IMEA - India, the Middle East, and Africa. The product is for medical tape applications to be used in stick-to-skin under unique climatic conditions, such as the high temperatures and humidity in the Indian sub-continent.
On February 1, 2024, Henkel introduced next-generation instant adhesives for medical device applications. The new products are formulated without CMR (Carcinogenic, Mutagenic or Reproductively hazardous) ingredients and are designed to offer increased strength during and after heat cycling.
To visualize the U.S. medical adhesives and sealants market segmentation based on type, application, end-users and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of medical adhesives and sealants market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.
The U.S. medical adhesives and sealants market report would provide approximately 53 tables, 47 figures and 176 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies